baber/WOPTO huggingface dataset:
Patent BR-PI1102209-B1 (BR)
Title: suspensão com plataforma flutuante para veículos
Inventor: NILTON PEDRO MAUSS
IPC: B60G21/00
Filed: 2011-05-18
Abstract: SUSPENSÃO COM PLATAFORMA FLUTUANTE PARA VEÍCULOS, compreendendo uma estrutura capaz de receber amortecedores, molas e demais componentes, de modo a possibilitar uma melhor dirigibilidade do veículo, desde que o centro de gravidade do veículo fique abaixo do ponto de fixação da suspensão. Dessa forma, a força centrífuga mantém o carro nivelado nas curvas, com as quatro rodas ao chão e ao mesmo tempo, continuar com as quatro rodas independentes.
Patent EA-001105-B1 (EA)
Title: Fungicide mixtures
Inventor: MULLER BERND
IPC: A01N37/52
Filed: 1997-04-23
Abstract: 1. A fungicidal composition comprising  a) a carbamate of the formula I   where T is CH or N, n is 0, 1 or 2 and R is halogen, C1-C4-alkyl or C1-C4-haloalkyl, it being possible for the radicals R to be different when n is 2, and/or b) an oxime ether of the formula II   where the substituents have the following meaning: X is oxygen or amino group (NH); Y is CH or N;  Z is oxygen, sulfur, amino group (NH) or C1-C4alkylamino group (N-C1-C4 alkyl); R' is C1-C6alkyl, C1-C6 haloalkyl, C3-C6 alkenyl, C2-C6 haloalkenyl, C3-C6 alkynyl, C3-C6 haloalkynyl, C3-C6 cycloalkylmethyl, or benzyl which may be partially or fully halogenated and/or may carry one to three residues selected from the following: cyano group, C1-C4 alkyl, C1-C4 haloalkyl, C1-C4 alkoxy-, C1-C4 haloalkoxy- and C1-C4 alkylthio group; and  c) a carbamate of the formula III (CH3)2N-CH2CH2CH2-NH-CO2-CH2CH2CH3 (III) in a synergistically active amount. 2. The fungicidal composition defined in claim 1 wherein the weight ratio of the compound of formula III to the compound of formula I and/or II is from 200:1 to 0.1:1. 3. A method of controlling harmful fungi, which comprises treating the harmful fungi, their environment, or the plants, seeds, soils, areas, materials or spaces to be kept free from fungal infection with a compound of formula I and/or a compound of formula II as set forth in claim 1 and a compound of formula III as claimed in claim 1 in a synergistically active amount. 4. The method defined in claim 3, wherein the compound of formula I and/or the compound of formula II as claimed in claim 1, and the compound of formula III as claimed in laim 1, are applied simultaneously together or separately, or in succession. 5. The method defined in claim 3, wherein harmful fungi, their environment, or the plants, seeds, soils, areas, materials or spaces to be kept free from fungal infection are treated with a compound of formula I and/or a compound of formula II as claimed in claim 1 in the amount of from 0.005 to 0.5 kg/ha. 6. The method defined in claim 3, wherein harmful fungi, their environment, or the plants, seeds, soils, areas, materials or spaces to be kept free from fungal infection are treated with a compound of formula III as claimed in claim 1 in the amount of from 0.1 to 10 kg/ha.
Patent EA-005917-B1 (EA)
Title: Virucidal compositions
IPC: A61K31/19
Filed: 2002-02-13
Abstract: A method of inactivating viruses comprises contacting the virus with a virucidally effective amount of a composition consisting essentially of a C1 to C3 monohydroxy alcohol or a C2 to C4 diol and a sufficient amount of an acid to adjust the pH of the composition to below 4.6. Topical administration of the composition is preferred and is effective in treating lesions associated infections by viruses such as herpes simplex. Nasal deliverable forms are effective in treating symptoms due to viruses that cause the common cold. Pharmaceutical compositions for use in the present method are provided.
Patent EA-007855-B1 (EA)
Title: Linear basic compounds having nk-2 antagonist activity and formulations thereof
Inventor: SISTO ALESSANDRO
IPC: C07D417/12
Filed: 2002-10-28
Abstract: Described herein are compounds of formula (I) useful as antagonists of tachykinins in general, and in particular of neurokinin A; and the pharmaceutical formulations comprising the compounds of formula (I).
Patent EA-008143-B1 (EA)
Title: Immunogenic formulations of variable peptidic epitopes and process for preparation thereof
Inventor: TORRES JOSE V
IPC: A61K47/48
Filed: 2002-02-08
Abstract: A process is disclosed for preparation of a immunogenic peptide mixture in a single synthesis. The peptide mixture collectively represents the in vivo variability seen in immunogenic epitopes from a pathogen. The mixture is termed a hypervariable epitope construct (HEC). Immunization with a HEC evokes broadly reactive immunity against divergent strains of a pathogen upon which the HEC is based.
Patent EA-006699-B1 (EA)
Title: Vibration isolating pipe clip
Inventor: VAN WALRAVEN JAN
IPC: F16L55/035
Filed: 2003-08-04
Abstract: A vibration isolation pipe clip for securing a pipe to a support, in particular for securing a medium-carrying pipe to a wall or ceiling of a building. The pipe clip comprises a substantially annular, rigid pipe clip body which is composed of one or more parts and is provided with securing means for securing the pipe clip body to a support. A substantially annular vibration isolating member is provided, this vibration isolating member bearing against the inner circumference of the pipe clip body and ultimately being positioned between the outer circumference of the pipe and the pipe clip body. The vibration isolating member is made from a porous elastomer material, preferably vulcanized porous rubber with closed cavities and separating walls between them.
Patent EA-008250-B1 (EA)
Title: Novel phenylnaphthalene derivatives, method for production thereof and pharmaceutical compositions comprising the same
Inventor: POISSONNIER-DURIEUX SOPHIE
IPC: A61P15/18
Filed: 2003-11-04
Abstract: Compounds of formula (1):whereA = a groupR= an alkoxy group,Ris as defined in the description andp = 1, 2 or 3.
Patent EA-011568-B1 (EA)
Title: Methods and pharmaceutical compositions for reliable achievement of acceptable serum testosterone levels
Inventor: HUBNER DORIS
IPC: A61K47/44
Filed: 2004-03-15
Abstract: The present invention relates to pharmaceutical compositions, formulated for injectable administration, which comprises a testosterone ester, in particularly testosterone undecanoate, in a vehicle comprising castor oil and a co-solvent. Upon injecting the compositions according to a particular administration scheme, reliable levels of testosterone in serum in the normal physiological range is achieved for a long period. This allows for the use of the compositions in hormone replacement therapy and male contraception without concomitant monitoring of testosterone levels in serum by a physician.
Patent EA-015009-B1 (EA)
Title: Antigen binding molecules with increased fc receptor binding affinity and effector function
Inventor: UMANA PABLO
IPC: A61K39/395
Filed: 2004-11-05
Abstract: The present invention relates to antigen binding molecules (ABMs). In particular embodiments, the present invention relates to recombinant monoclonal antibodies, including chimeric, primatized or humanized antibodies specific for human CD20. In addition, the present invention relates to nucleic acid molecules encoding such ABMs, and vectors and host cells comprising such nucleic acid molecules. The invention further relates to methods for producing the ABMs of the invention, and to methods of using these ABMs in treatment of disease. In addition, the present invention relates to ABMs with modified glycosylation having improved therapeutic properties, including antibodies with increased Fc receptor binding and increased effector function.
Patent EA-012872-B1 (EA)
Title: ANTIBODIES TO MAdCAM
Inventor: PULLEN NICHOLAS
IPC: C12N5/06
Filed: 2005-01-07
Abstract: The present invention relates to antibodies including human antibodies and antigen-binding portions thereof that specifically bind to MAdCAM, preferably human MAdCAM and that function to inhibit MAdCAM. The invention also relates to human anti-MAdCAM antibodies and antigen-binding portions thereof. The invention also relates to antibodies that are chimeric, bispecific, derivatized, single chain antibodies or portions of fusion proteins. The invention also relates to isolated heavy and light chain immunoglobulins derived from human anti-MAdCAM antibodies and nucleic acid molecules encoding such immunoglobulins. The present invention also relates to methods of making human anti-MAdCAM antibodies, compositions comprising these antibodies and methods of using the antibodies and compositions for diagnosis and treatment. The invention also provides gene therapy methods using nucleic acid molecules encoding the heavy and/or light immunoglobulin molecules that comprise the human anti-MAdCAM antibodies. The invention also relates to transgenic animals or plants comprising nucleic acid molecules of the invention.
Patent EA-010605-B1 (EA)
Title: Method for detecting open flame (embodiments) and device therefor
Inventor: SHUSTROV SERGEY VLADIMIROVICH
IPC: G08B17/12
Filed: 2007-02-12
Abstract: Open flame detection method (embodiments) and device therefor relates to measuring technology, in particular, to flame detectors, when burning in the control area with recognition of solar radiation and welding radiation.The engineering problem involves creation of the open flame detection methods and device allowing to reduce the risk of false alarm on account of difference in radiation of close and remote flame of solar radiation, electric-arc and gas welding and artificial light sources and enhancement of optical interference protection and improvement of the capability to detect real flame in the control area without reference to distance.The proposed invention is based on the first time proposed capability to detect open flame additionally by the signal analysis received after deduction of the compensating channel signal amplitude from the main channel signal amplitude and respectively entering into the flame detection device of the subtracting channel. Besides, with reference to the second embodiment separation of pulses typical of flame and interference by means of controllable band pass filters by the second frequency band is unobvious in terms of the common knowledge with reference to the third embodiment-elimination of interference by means of the envelope.So, the technical result achieved by said invention is not determined by known influence of distinguished features and cannot be predicted using the information comprised in the prior art.
Patent EA-015170-B1 (EA)
Title: High viscosity diutan gums and methods of producing
Inventor: HARDING NANCY E
IPC: C12P19/04
Filed: 2006-10-31
Abstract: The present invention describes the production of a diutan polysaccharide exhibiting increased viscosity properties as compared with previously produced polysaccharide of the same type of repeating units. Such an improved diutan polysaccharide is produced through the generation of a derivative of Sphingomonas sp. ATCC 53159 that harbors a multicopy broad-host-range plasmid into which genes for biosynthesis of diutan polysaccharide have been cloned. The plasmid provides the capability within the host Sphingomonas strain to produce multiple copies of genes for such polysaccharide synthesis. In such a manner, a method of not just increased production of the target diutan polysaccharide, but also production of a diutan polysaccharide of improved physical properties (of the aforementioned higher viscosity) thereof is provided.; Such a diutan polysaccharide has proven particularly useful as a possible viscosifier in oilfield applications and within cement materials. The inventive methods of production of such an improved diutan polysaccharide, as well as the novel cloned genes required to produce the improved diutan within such a method, are also encompassed within this invention. Additionally, the novel engineered Sphingomonas strain including the needed DNA sequence is encompassed within this invention.
Patent EA-022130-B1 (EA)
Title: Di-fluoro containing compounds as cysteine protease inhibitors
Inventor: LINK JOHN O
IPC: C07C255/46
Filed: 2007-10-03
Abstract: The present invention is directed to compounds that are inhibitors of cysteine proteases, in particular, cathepsin S, and are therefore useful in treating diseases mediated by these proteases. The present invention is directed to pharmaceutical compositions comprising these compounds and processes for preparing them.
Patent EA-016680-B1 (EA)
Title: Resonance energy converter
Inventor: VASHINKO DMITRIJ DMITRIEVICH
IPC: H02M5/14
Filed: 2009-09-14
Abstract: The invention relates to the field of energetic and is intended for use in a variety of industries for the supply of electrical devices, such as machining and welding equipment, lighting systems, electric drives of water supply wells, career excavators, building lots and other similar objects. EFFECT: reduction of electric energy consumption, compensation of under voltage at the supply lines, electrical power with low cos φ. The converter contains a power unit, which includes many non-inductive-capacitive resonant circuits (L-L)Cand LCtuned to resonance, one of which (L-L)Cis made private and functionally related to the winding of electrical machine. Inductive-capacitive chains 6, 7, 8 of closed circuits (L-L)Cpowered on in the form of a star. Loose ends of capacities Cintegrated in the central point "0", and the point "0" of their connection is closed on alternating potential with respect to its own infinity "∞" with the possibility of resonance current in the winding of electrical load of the machine.
Patent EA-020083-B1 (EA)
Title: Dehydration of alcohols on crystalline silicates
Inventor: MINOUX DELPHINE
IPC: C07C1/24
Filed: 2009-02-05
Abstract: The present invention relates to a process for the dehydration of at least an alcohol to make at least an olefin, comprising: introducing in a reactor a stream (A) comprising at least an alcohol, optionally water, optionally an inert component, contacting said stream with a catalyst in said reactor at conditions effective to dehydrate at least a portion of the alcohol to make an olefin, recovering from said reactor an olefin containing stream (B), wherein the catalyst is a crystalline silicate having a ratio Si/Al of at least about 100, or a dealuminated crystalline silicate, or a phosphorus modified zeolite, the WHSV of the alcohols is at least 2 h, the temperature ranges from 280 to 500°C. It relates also to the same process as above but wherein the catalyst is a phosphorus modified zeolite and at any WHSV. The partial pressure of the alcohol in the dehydration reactor advantageously ranges from 1.2 to 4 bars absolute (0.12 to 0.4 MPa), the temperature of the dehydration reactor ranges advantageously from 300 to 400°C and the alcohol is selected among ethanol, propanol, butanol and phenylethanol.
Patent EA-020447-B1 (EA)
Title: Display device comprising display elements without backflow ducts
Inventor: MUELLER-MARC OLIVER
IPC: G02F1/19
Filed: 2011-03-25
Abstract: The invention relates to a display device having at least one electronically controllable display element comprising at least one non-polar and at least two electrically conducting or polar liquids, a fluidically closed volume having a first subvolume, a second subvolume and at least two storage volumes connected to said subvolumes, as well as a voltage source connected to a first electrode array. It is provided thereby that each of said electrically conducting or polar liquids assumes a volume which is dimensioned such that, independent of application of voltage to the electrode array, always a fluidically tight closure for non-polar liquid between the respective storage volume and either the first or the second subvolume is formed.
Patent EA-025702-B1 (EA)
Title: Furnace and heating device comprising a thermal barrier and a heating method associated with said furnace
Inventor: FANTON XAVIER
IPC: F27D99/00
Filed: 2010-04-06
Abstract: The invention relates to a furnace for heating an object in one location, comprising a refractory ceramic wall and a heat source, characterized in that it comprises at least one metal plate coated with an adhesive layer of a ceramic material on one of the main faces thereof, said coated plate being placed between the wall and the source and the adhesive layer facing the source. The coated metal plate acts as a thermal barrier and improves the heating effectiveness of the heat source. The furnace is intended in particular for the gravity bending of glass sheets placed on a bending frame.
Patent EA-022278-B1 (EA)
Title: Pharmaceutical composition for the prophylaxis and treatment of infectious and non-infectious diarrhoea
Inventor: DIKOVSKIY ALEKSANDER VLADIMIROVICH
IPC: A61P1/00
Filed: 2010-09-21
Abstract: A pharmaceutical composition for the prophylaxis and treatment of infectious and non-infectious diarrhoea consists of medicinal hydrolysed lignin and living cells of the yeast strain Saccharomyces boulardii in the amount of 10-5×10of living yeast cells to 1 gram of hydrolysed lignin. Preferably, the composition is prepared by uniformly mixing a lyophilized powder of living cells, i.e. cells in an anabiotic state, of the yeast strain Saccharomyces boulardii with powdered medicinal lignin. This drug (pharmaceutical composition) is proposed preferably as a general remedy for diarrhoea occurring during travel, when it is difficult to make a diagnosis and establish the cause of intestinal upset and an effective drug is urgently required, before consultation with a doctor, which will have a sorbing and marked antimicrobial and antiviral effect, as well as a normalizing effect on intestinal motor function. Furthermore, the range of diarrhoeal causative agents that can be suppressed is increased, and discrepancies are reduced and treatment times are shortened with respect to other diverse causative agents of bacterial food poisoning.
Patent EA-023839-B1 (EA)
Title: Combinations of a muscarinic receptor antagonist and a beta-2 adrenoreceptor agonist
Inventor: BAKER DARRELL
IPC: A61P11/08
Filed: 2010-11-29
Abstract: The invention provides a pharmaceutical combination product comprising a) 4-[hydroxy(diphenyl)methyl]-1-{2-[(phenylmethyl)oxy]ethyl}-1-azoniabicyclo[2.2.2]octane bromide and b) 4-{(1R)-2-[(6-{2-[(2,6-dichlorobenzyl)oxy]ethoxy}hexyl)amino]-1-hydroxyethyl}-2-(hydroxymethyl)phenol triphenylacetate for inhaled administration via the nose or mouth, a dry powder inhaler comprising said product, and the use thereof for the treatment of chronic obstructive pulmonary disease.
Patent EA-023901-B1 (EA)
Title: Wheel set guide for rail vehicles
Inventor: WRITSCHAN JOERG
IPC: B61F5/30
Filed: 2011-09-15
Abstract: The invention relates to a wheel set guide for rail vehicles. According to the invention the wheel set guide for rail vehicles comprises a wheel set shaft mounted on a roller bearing, a frame element, an inner element in the form of a bearing bushing accommodating the wheel set, an inner support element and an outer support element that is joined rigidly to the frame element. In accordance with the idea of the present invention, the inner support element is mounted between the inner element and the outside element, the wheel set shaft with the roller bearing being mounted rotatably inside the inner element. The device further includes metal wire cushions arranged between the inner support element and the outer support element, wherein metal wire cushions are designed as guide rods and are located on both sides of the wheel set shaft to guide the wheel set travel in the direction of movement, and a metal wire cushion is implemented as a supporting cushion for transmitting the vertical load between the wheel set and the frame element in the vertical direction and is arranged perpendicularly above the shaft.
Patent EA-022695-B1 (EA)
Title: Controlling decanter phase separation of acetic acid production process
Inventor: HALLINAN NOEL
IPC: C07C53/12
Filed: 2011-07-15
Abstract: Disclosed is a method for controlling the decanter phase separation of an acetic acid production by methanol carbonylation. The method comprises measuring the methyl acetate concentration of the reactor mixture, calculating the density of the decanter heavy, organic phase according to the measured methyl acetate concentration, and adjusting the conditions in the reactor or in the decanter to ensure phase separation of the decanter.
Patent EA-025781-B1 (EA)
Title: Modular coater separation
Inventor: LECOMTE BENOIT
IPC: C23C16/54
Filed: 2011-10-18
Abstract: The invention relates to a process for depositing under vacuum a multilayers coating stack on a flat glass substrate and to a modular coater for the deposit of thin layers on a flat glass substrate. A gas separation zone disposed between two depositing zones of the modular coater comprises at least one gas injector in the vicinity of the convoying path for the glass substrate which passes through apertures from a depositing zone towards the other depositing zone via the separation zone. The invention allows improvement of the separation factor between the two depositing zones.
Patent EA-027082-B1 (EA)
Title: Imidazole derivatives as pde10a enzyme inhibitors
Inventor: KEHLER JAN
IPC: C07D519/00
Filed: 2011-11-18
Abstract: The invention is directed to compounds of formula I which are PDE10A enzyme inhibitors. The invention relates to a pharmaceutical composition for treating a neurodegenerative or psychiatric disorder comprising a therapeutically effective amount of a compound of the invention and one or more pharmaceutically acceptable carriers, diluents and excipients. The present invention also relates to a process for the preparation of the compounds of formula I.
Patent EA-027720-B1 (EA)
Title: Method for producing sildenafil-free base-containing film
Inventor: JEON HONG-RYEOL
IPC: A61K31/519
Filed: 2012-02-13
Abstract: The invention relates to embodiments of a method for producing a film containing a sildenafil free base, wherein the embodiments comprise drying a polymer solution in which a sildenafil free base is dispersed, wherein the sildenafil free base has such a particle size distribution in which a particle diameter (D10) corresponding to 10% of the distribution is 8 μm or more and a particle diameter (D90) corresponding to 90% of the distribution is 100 μm or less.
Patent EA-024575-B1 (EA)
Title: Method for production of alloyed titanium welding wire
Inventor: JENSRUD OLA
IPC: C22F1/18
Filed: 2012-03-21
Abstract: The invention relates to a method for producing a weldable titanium alloy and/or composite wire by cold compaction, extrusion and rolling of a blended mixture of titanium sponge and alloying additions and/or reinforcing particles. The present method comprises the following successive process steps: a) forming a green object by blending particulates of titanium sponge with a particle diameter in the range from 0.5 to 10 mm with one or more powdered alloying additions with particle size in the range from 50-250 μm, cold compacting the blended mixture and subjecting the blended mixture including lubricant to a pressure in the range from 750 to 1250 Mpa; b) forming a work body of alloyed titanium by heating the green object in a protected atmosphere up to a temperature in the range from 1000 to 1250°C and holding the temperature for a period of at least 4 hours, and then hot working the green object at a temperature of less than 200°C apart from the beta transition temperature of the titanium alloy and shaping the green object to obtain an elongated profile; and c) rolling the elongated titanium alloy profile body in a rolling mill with one or more rolls placed in series to form the weldable wire with the desired diameter.